ANTIBODY COVID-19 TESTING

Serology Test Webinar and Q/A with Dr. O'Gorman,

Chief of Laboratory Medicine & Director of Clinical Lab, CHLA
 

 

 

ANTIBODY COVID-19 TESTING AT CHLA DRIVE THROUGH

REMINDER: Please be sure to fill out all demographic and insurance information.

As of Tuesday, April 21, CHLA started performing blood draw antibody samples for Anti-SARS-CoV-2 Antibody IgG at the the drive through location at CHLA. This service is open to Health Network physicians, staff and patients. If you as the physician would like testing, please have a colleague as the ordering physician.

What do you need to do? 

Please sure to complete the “Clinical Requisition Form.” document. Results will be faxed to the number indicated on this form 1 to 4 days after the sample arrives in the Immunology Laboratory

 

What does your patient need to do?

We request the patient bring  1) the Clinical Requisition Form. and 2) complete patient insurance information, and 3) the drive through directions and instructions.

 

CHLA

Rodney Parking Garage

4650 Sunset Blvd

Los Angeles, CA 90027

Mon - Fri: 6:00am – 2:00pm 

 

Please note that this test requires a venipuncture blood draw.  The family will be directly to the phlebotomy tent to have the sample drawn safely.

For cash pay patients, it will be $75 plus a $38 venipuncture fee. 

ANTIBODY COVID-19 TESTING AT SATELLITE LOCATIONS 

Please note the Pasadena lab is closed until July 6th 

As of Friday, April 17, CHLA started performing blood draw antibody samples for Anti-SARS-CoV-2 Antibody IgG at the outreach satellite locations in Pasadena and Encino. This service is open to Health Network physicians, staff and patients. If you as the physician would like testing, please have a colleague as the ordering physician.

 

What do you need to do?

Please be sure to complete the Clinical Requisition Form. Results will be faxed to the number indicated on this form 1 to 4 days after the sample arrives in the Immunology Laboratory. To help alleviate wait time, we request that prior to sending the patient, please fax 1) the Clinical Requisition Form and 2) complete patient insurance information ahead of time for registration.

 

What does your patient need to do?

If you are unable to fax the requisition, please be sure to send the Clinical Requisition Form with the patient to present at the location. The patient will need to go to one of the locations below to be tested. 

Below are the locations for the laboratories performing the testing:

                                                               

Encino - Lab and NP Swab testing

5359 Balboa Blvd. Suite B 

Encino, CA 91316             

Phone: 818-728-4930

Fax: 818-728-4932

Mon-Fri: 8:00am – 12:00pm

               1:00pm – 5:00pm 

South Bay - Lab testing only

3440 Torrance Blvd., Suite 100

Torrance, CA 90503

Phone: 310-303-3890

Fax: 310-303-3893

Mon-Fri: 8:00am – 12:00pm

               1:00pm – 5:00pm

Pasadena - Lab testing only

*location closed until July 6th*

800 S Fairmount Ave. Suite 115

Pasadena, CA 91105

Phone: 323-361-8063

Fax: 323-361-4904

Mon-Fri: 8:00am – 12:30pm

               1:30pm – 5:00pm

Arcadia - Lab testing only

468 E Santa Clara St

Phone: 626-795-7177

Fax: 626-357-4052

Arcadia Ca 91016

Mon-Fri: 8:00am – 12:00pm

               1:00pm – 5:00pm

The satellite locations will be open Mon-Fri at the times listed above. However, testing at the laboratories will be run only on Tuesdays and Thursdays, but may increase based on demand.

Please note that effective June 1, 2020, the Encino location offers NP Swab COVID-19 testing, 8 am - 12 pm, for pre- procedural and pre-admission testing only.

Please refer to the “Health Network: Antibody IgG Testing for COVID-19”document below for more information. If you will be utilizing any of the above services, prior to sending a patient, please make sure to inform Felicia Hoodbhoy at fhoodbhoy@chla.usc.edu or 714-383-0751.

NECESSARY DOCUMENTS

CODING INFORMATION

86328  single step e.g. reagent strip, for infectious agent antibody(ies), qualitative or semiquantitative ; severe acute respiratory syndrome.  This is the POCT in office. 

86769  serology method, Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]). This is the CHLA test. 

For more information on CDC ICD COVID-19 guidelines please click here

Please note that with the early release of these CPT codes, the health plans need to manually upload these code descriptors into their claims system and fee schedules. This delay may result in processing errors. If you experience claim errors, please reach out to Jacki DeLanders at jdelanders@chla.usc.edu or call 323.376.1713 for assistance.   

RESULT INTERPRETATION

By way of background on serology testing, this test can identify if an individual has been exposed to COVID-19 and already developed antibodies against the virus.  

 

Though it has not yet been fully validated for novel coronavirus, it is believed that individuals who have already developed antibodies could be protected against reinfection with SARS-COV-2. Also, for individuals who have antibodies, there are currently no changes to the guidance for daily activities during this crisis—meaning that, regardless of test results, individuals would still have to comply with Safer at Home orders, physical distancing requirements of six feet, universal masking and all other PPE requirements and guidance related to COVID-19.   

 

There are some immediate benefits of knowing this information:  people who have fully recovered from COVID-19 and have antibodies in their plasma can donate it to others who need help fighting the virus. Historically, plasma has been used as a potentially lifesaving treatment when new disease or infections develop quickly with no current treatments or vaccines yet available. It is anticipated that, in the future, those who have developed antibodies may be able to be provided with different personal protective equipment recommendations as guidance becomes available from the CDC and other health agencies.  

 

Both state and federal agencies are looking into how antibodies will be used in the future.  CHLA takes pride in being able to contribute to this work

Click here to review a fact sheet on anti-SARS-CoV-2 antibody IgG for providers and here to review a fact sheet on anti-SARS-CoV-2 antibody IgG for patients.

©2020 by CHLA Health Network. Proudly created with Wix.com